Home Deals
deals
Covid has shown a new way of working in healthcare, and there are lessons for private equity, say CVC’s Cathrin Petty and Phil Robinson.
The adoption of virtualisation has been gathering pace for some time, but covid has helped the industry reach an inflexion point, says Rowena Gracey, director at 3i.
High entry multiples are forcing private equity firms to get creative Down Under.
Rising multiples have not weakened enthusiasm for a segment that has historically outperformed the rest.
Subtitle of Automation test 2 Related news
EBITDA addbacks became an increasing cause for concern in 2019 as borrowers stretched the bounds of permissible adjustments.
In the final part of our series on private equity metrics, PEI examines why the internal rate of return can flatter to deceive.
Private equity relies on metrics to make some of its most crucial decisions, but do they tell the whole story? In the first of four articles, we take a closer look at the "shapeshifting" EBITDA.
Capital raising, deal financing and talent retention will face more challenges, according to panellists at a private equity conference in London.
Revenue growth is strong and dealflow is rising, breaking past 3,000 deals last year